drugset / Trial / NCT00108251

Aldosterone Antagonism in Diastolic Heart Failure

NCT00108251

Phase 4 Completed 48 enrolled US Department of Veterans Affairs
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary purpose of this study is to determine whether eplerenone has a beneficial effect on improving exercise ability in patients with diastolic heart failure.

Timeline

Start
2004-08
Primary completion
2007-09
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Eplerenone Unknown 50 mg